Successful immunotherapy for cancer involves activating a person’s own T cells to identify telltale proteins…
karnottFebruary 28, 2024
Explore Now
News and Articles
The phase III JAVELIN Renal 101 trial demonstrated prolonged progression-free survival (PFS) in patients (N = 886)…
karnottFebruary 28, 2024
In August 2008, Shamim Dahod (CGS’76, CAS’78, CAMED’87) and her husband Ashraf gave $10.5M to…
karnottFebruary 27, 2024
In his efforts to advance the development of a low-cost, compact medical device for screening…
karnottFebruary 27, 2024
A type of immune therapy called chimeric antigen receptor (CAR)-T cell therapy has revolutionized the…
pthomsonMarch 16, 2023
A novel hematopoietic stem cell transplantation (HSCT) method utilizing ‘graft sculpting’ is being tested in…
pthomsonMarch 16, 2023
Sam Wattrus came to Harvard as an undergraduate thinking he would study chemistry. But he…
pthomsonMarch 16, 2023
For physicians, scientists, and patients, neurodegenerative diseases, which affect millions of people in this country…
pthomsonMarch 15, 2023
News and Articles
UMass Chan Medical School and Astellas Pharma Inc., a pharmaceutical company conducting business in more…
karnottJune 25, 2024
Patients with a genetic syndrome called NF2-related schwannomatosis (NF2-SWN) have tumors that develop on the…
karnottJune 25, 2024
CRISPR/Cas9 gene editing has made possible a multitude of biomedical experiments including studies that systematically…
karnottJune 24, 2024
Upcoming Events in Boston
Stay up-to-date with all of the life science events taking place in Boston with the Science in Boston events calendar!
